Société Générale: Good timing to anticipate taking profits
Published on 06/10/2021
at 01:01 pm IST
| Entry price | Target | Stop-loss | Potential |
|---|
|
€26.34 |
€24.42 |
€26.92 |
+7.29% |
|---|
Société Générale shares could experience selling pressure following the strong increase in its stock price. Over the short term, the stock in fact displays first signs of exhaustion.
SummaryStrengths● Its low valuation, with P/E ratio at 8.68 and 7.9 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
●
● This company will be of major interest to investors in search of a high dividend stock.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● For several months, analysts have been revising their EPS estimates roughly upwards.
●
●
● Historically, the company has been releasing figures that are above expectations.
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
●
© MarketScreener.com -
2021
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener India. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
